Join us for a conversation with Peter Saltonstall, President and Chief Executive Officer at the National Organization for Rare Disorders (NORD) for a discussion on the major opportunities and challenges facing rare diseases.
Peter has been a leader in the healthcare field for over 30 years. Under his leadership, NORD has forged new relationships between the patient community and the Congress, FDA, NIH and Social Security Administration, as well as with drug/device companies and the medical/academic investment communities. His efforts to build collaborations stem from his view that advances for the rare disease patient can be achieved through joint efforts.
Session ID: 551551